Home Zacks Gives Neutral Rating to Teva Pharmaceutical Industries Ltd
 

Keywords :   


Zacks Gives Neutral Rating to Teva Pharmaceutical Industries Ltd

2013-02-12 11:19:20| Biotech - Topix.net

The firm currently has a $41.00 target price on the stock. Zacks' analyst wrote, "Teva's fourth quarter earnings of $1.32 per American Depositary Share were a penny short of the Zacks Consensus Estimate and 17% below the year-ago earnings.

Tags: rating ltd industries neutral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »